Bone Growth Stimulators Market Worth USD 1.41 Billion in 2022 Bone Growth Stimulator Market | Page 2

safety and efficacy of stimulators in fusion surgery, and increasing use of bone growth stimulation
products.
Browse and in-depth TOC on "Bone Growth Stimulators Market"
66 - Tables
67 - Figures
153 - Pages
View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/bone-growth-stimulator-market-
82341383.html
On the basis of end user, the global bone growth stimulators market is segmented into hospitals
& clinics, home care, and academic & research institutes and CROs. The hospitals & clinics
segment is expected to grow at the highest CAGR during the forecast period. The advantage of
bone growth stimulation products over their counterparts is the key factor driving their adoption
in this end-user segment.
On the basis of region, this bone growth stimulators market is classified into North America,
Europe, Asia-Pacific, and the Rest of the World. In 2016, the global bone growth stimulators
market was dominated by North America mainly due to the growing elderly population,
increasing incidence of arthritis and sports injuries, adoption of novel treatment options, and
rising demand for minimally invasive spinal surgeries.
Request for Free Sample Report @
https://www.marketsandmarkets.com/requestsample.asp?id=82341383
However, the Asia-Pacific market is expected to grow at the highest CAGR during 2017–2022.
This is primarily due to the presence of a large patient population for target diseases (coupled
with rapidly growing geriatric population, especially in Japan and China), rising awareness among
healthcare professionals related to novel and upcoming treatment options, and ongoing
government initiatives to modernize & expand healthcare infrastructure.
Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.),
Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.),
Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.) are some of the key players in
the bone growth stimulators market.
2